There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...

For decades, researchers from all obesity-related disciplines have been observing the escalating prevalence of people living ...

Fintel reports that on November 14, 2024, JP Morgan initiated coverage of Blueprint Medicines (NasdaqGS:BPMC) with a ...

Nearly three quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Over the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least ...

In a little over two decades, almost 260 million people in the United States are predicted to have overweight or obesity, ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Jefferies has recently reiterated Teladoc Health Inc (TDOC) stock to Hold rating, as announced on September 17, 2024, according to Finviz. Earlier, on February 29, 2024, Cantor Fitzgerald had ...

BlackRock Global Allocation V.I. Fund posted a return of 4.89% (Class I shares) for the third quarter of 2024, while its ...